Aspira Pathlab & Diagnostics Ltd.
| BSE: 540788 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE500C01017 |
| BSE 00:00 | 02 Dec | 42.55 |
-0.20 (-0.47%) |
OPEN
43.40 |
HIGH
43.50 |
LOW
42.50 |
| NSE 05:30 | 01 Jan | Aspira Pathlab & Diagnostics Ltd |
| OPEN | 43.40 |
| PREVIOUS CLOSE | 42.75 |
| VOLUME | 408 |
| 52-Week high | 107.80 |
| 52-Week low | 38.00 |
| P/E | 21.49 |
| Mkt Cap.(Rs cr) | 44 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aspira Pathlab & Diagnostics Ltd. (ASPIRAPATHLAB) - Announcements
-
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
28/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations An
25/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
25/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Change in Directorate
12/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Financial Results For The Quarter Ended September 30 2022
12/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Financial Results For The Quarter Ended September 30 2022
12/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2022
12/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Board Meeting Intimation for The Meeting Of Board Of Directors Of The Company To Be Held On 12Th Nov
05/11/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Statement Of Investor Complaints For The Quarter Ended September 2022
08/10/2022 | bse
-
Aspira Pathlab & Diagnostics Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/10/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
03/10/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
03/10/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
30/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Closure of Trading Window
30/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
30/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
27/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
24/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
20/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
15/09/2022 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
12/09/2022 | bse
Quick Links for Aspira Pathlab & Diagnostics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
